Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Asset Utilization Ratio: 2019-2025

Historic Asset Utilization Ratio for BridgeBio Pharma (BBIO) over the last 6 years, with Sep 2025 value amounting to 0.34.

  • BridgeBio Pharma's Asset Utilization Ratio rose 14.07% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year increase of 14.07%. This contributed to the annual value of 0.30 for FY2024, which is 1803.08% up from last year.
  • Per BridgeBio Pharma's latest filing, its Asset Utilization Ratio stood at 0.34 for Q3 2025, which was up 41.61% from 0.24 recorded in Q2 2025.
  • BridgeBio Pharma's 5-year Asset Utilization Ratio high stood at 0.34 for Q3 2025, and its period low was -0.00 during Q1 2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.24 (2025), whereas its average is 0.19.
  • Per our database at Business Quant, BridgeBio Pharma's Asset Utilization Ratio plummeted by 105.33% in 2021 and then skyrocketed by 2,552.92% in 2024.
  • Quarterly analysis of 5 years shows BridgeBio Pharma's Asset Utilization Ratio stood at 0.01 in 2021, then surged by 883.85% to 0.11 in 2022, then slumped by 86.52% to 0.02 in 2023, then surged by 1,708.76% to 0.28 in 2024, then rose by 14.07% to 0.34 in 2025.
  • Its last three reported values are 0.34 in Q3 2025, 0.24 for Q2 2025, and 0.14 during Q1 2025.